Table 5.
The top 20 keywords of immunotherapy-TME-related research.
| Rank | Keyword | Cluster | Occurrences | Percent(%) | Rank | Keyword | Cluster | Occurrences | Percent(%) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Immunotherapy | 3 | 5101 | 13.26 | 11 | Biomarkers | 2 | 381 | 0.99 |
| 2 | Cancer | 1 | 3971 | 10.32 | 12 | Immune Checkpoints | 2 | 361 | 0.94 |
| 3 | TME | 1 | 3397 | 8.83 | 13 | Dendritic Cells | 1 | 337 | 0.88 |
| 4 | Immune Checkpoint Inhibitors | 2 | 822 | 2.14 | 14 | Immunosuppression | 1 | 303 | 0.79 |
| 5 | PD-1&PD-L1 | 2 | 757 | 1.97 | 15 | Tumor-Infiltrating Lymphocytes | 2 | 273 | 0.71 |
| 6 | Immune | 1 | 626 | 1.63 | 16 | NK Cells | 1 | 221 | 0.57 |
| 7 | Prognosis | 2 | 592 | 1.54 | 17 | Nanomedicine | 3 | 217 | 0.56 |
| 8 | Tumor-Associated Macrophages | 1 | 540 | 1.4 | 18 | Chemotherapy | 3 | 215 | 0.56 |
| 9 | T Cells | 1 | 454 | 1.18 | 19 | Combination Therapy | 3 | 196 | 0.51 |
| 10 | Cancer Vaccines | 1 | 436 | 1.13 | 20 | Radiotherapy | 3 | 194 | 0.5 |